Don't miss an issue! Renew/subscribe for FREE today.
×

Solmetex Announces Purchase of Syclone™ Amalgam Separator System From Crosstex

Posted on Monday, December 16, 2019

Solmetex NXT Hg5® Amalgam Separator Systems to replace Syclone

Solmetex, LLC. announced today the acquisition of the Syclone Amalgam Separator System from Crosstex.

For over 25 years, Solmetex has been an innovator in waste solutions, specifically amalgam separators, with a primary focus on ensuring dental practices remain compliant with the ever-changing regulatory environment. The acquisition will allow Solmetex to continue its commitment to deliver best-in-class, environmentally responsible dental waste solutions and programs to its physician partners and the communities they serve.

Following the recent acquisition of Hu-Friedy by Cantel, the Hu-Friedy and Crosstex businesses are integrating to form the new Cantel dental division. The sale of the Syclone System comes as part of the decision to focus on the Hu-Friedy Crosstex leadership and expertise in the areas of instrument reprocessing workflow and infection prevention and compliance solutions in dentistry.

“We anticipate a high growth of the amalgam separator business and with our ongoing other priorities, we will not have the infrastructure needed to provide the proper level of support for this product,” said Ken Plunkett, SVP Global Sales of Crosstex. “We reached out to Solmetex, as the leading provider in this category because we are committed to ensuring the best possible transition for our distribution partners and their customers.”

“Solmetex, has been recognized as the leading technology in Amalgam Separation for over 25 years, with our system installed in over 50,000 dental offices worldwide,” stated Kevin Danahy, President of Solmetex. “With the introduction of our NXT Hg5 system in 2017, we continued our technology evolution, pairing it with our best-in-class customer support that physicians and their practice staff have come to rely on. We look forward to continuing this same tradition of excellence with Syclone users both today and in the years to come.”

Transition plans are currently under development and current Syclone users are asked to contact their local dealer or Solmetex at www.solmetex.com to address any questions and coordinate their transition to the NXT Hg5 Amalgam Separation System.

About Solmetex, LLC

Solmetex provides waste management services through a series of specialized processes and systems that cost-effectively remove mercury from the waste stream and offers additional dental waste solutions. The company’s NXT Hg5® Series of Amalgam Separators and recycling program, which treat dental wastewater, is highly regarded as the best solution for regulatory compliance. Solmetex is widely recognized as the single trusted source for comprehensive environmental solutions for the dental waste needs.

For further information, visit www.solmetex.com.

About Cantel Medical Corp.

Cantel Medical Corp. is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers, which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.

For further information, visit www.cantelmedical.com.

About Crosstex International, Inc.

Crosstex International, Inc., the Dental division of Cantel Medical Corp., manufactures a wide array of unique and innovative infection prevention and compliance products for the global healthcare industry. Founded in 1953 and headquartered in Hauppauge, New York, Crosstex is a recognized leader for its portfolio of waterline treatment and compliance solutions, biological monitoring, sterility assurance, and preventive products, nitrous oxide sedation, and personal protection equipment (PPE).

For further information, visit www.crosstex.com.

 







AADR Elects Sonia K. Makhija as AADR Representative to the IADR/AADR Publications Committee

Posted on Monday, December 16, 2019

Members of the American Association for Dental Research (AADR) have elected Sonia K. Makhija, University of Alabama at Birmingham School of Dentistry, to serve as the 2020-2023 AADR Representative to the IADR/AADR Publications Committee.

Her term will commence at the conclusion of the 98th General Session of the International Association for Dental Research (IADR), which will be held in conjunction with the 49th Annual Meeting of the AADR and the 44th Annual Meeting of the Canadian Association for Dental Research (CADR), from March 18-21, 2020 in Washington, D.C.

Makhija received a B.A. and D.D.S from the University of Missouri – Kansas City and a M.P.H from the University of Alabama at Birmingham. Her career has included several aspects of dentistry including private practice, serving as a dental examiner for the National Health and Nutrition Survey (NHANES) and completing a T-32 postdoctoral training in Caries Research.

Makhija currently serves as the Assistant Node Director for the South Central Region and Director of Communications and Dissemination for the National Dental Practice-Based Research Network, a consortium of participating practices and organizations committed to advancing knowledge of dental practice and ways to improve it. She is also a dentist at the Fairhaven Nursing Home Dental Clinic in Birmingham, Ala.

Since joining IADR/AADR in 2003, Makhija has held several roles. She served on the AADR Fellowships Committee and is currently serving as the Councilor for the Alabama AADR Section and the North American Director for the IADR Behavioral, Epidemiologic and Health Services and Research Scientific Group (BEHSR). Makhija is a member of the IADR Evidence-based Dentistry Network and the IADR BEHSR.

International Association for Dental Research

The International Association for Dental Research (IADR) is a nonprofit organization with over 10,000 individual members worldwide, with a Mission to drive dental, oral and craniofacial research to advance health and well-being worldwide. To learn more, visit www.iadr.org. The American Association for Dental Research (AADR) is the largest Division of IADR with over 3,000 members in the United States. To learn more, visit www.iadr.org/aadr.







AADR Elects Jane A. Weintraub as AADR Vice-President

Posted on Monday, December 16, 2019

Members of the American Association for Dental Research (AADR) have elected Jane A. Weintraub, University of North Carolina at Chapel Hill, to serve as the AADR Vice-president. Her term will commence at the conclusion of the 98th General Session of the International Association for Dental Research (IADR), which will be held in conjunction with the 49th Annual Meeting of the AADR and the 44th Annual Meeting of the Canadian Association for Dental Research (CADR), from March 18-21, 2020 in Washington, D.C.

Weintraub received a D.D.S. from the State University of New York at Stony Brook and completed her M.P.H and Postdoctoral Fellowship at Harvard University, Boston, Mass. She is the R. Gary Rozier and Chester W. Douglass Distinguished Professor in Dental Public Health and former Dean of the University of North Carolina at Chapel Hill, Adams School of Dentistry and an Adjunct Professor at the University of North Carolina at Chapel Hill, Gillings School of Global Public Health.

Weintraub’s research has focused on the epidemiology and prevention of oral conditions and oral health disparities, with an emphasis on conducting prevention-oriented clinical trials. Her patient and population-based research, with applications to dental patients or the larger community, spans the continuum of epidemiology, clinical research and health policy. Weintraub’s research has helped shape scientific guidelines regarding sealants and fluoride that have become a part of mainstream dental and public health practices.

Since joining IADR/AADR in 1979, Weintraub has held several AADR leadership positions such as AADR Board Member-at-Large, President and Group Councilor of the IADR Behavioral, Epidemiologic and Health Services Research Group and President of the AADR North Carolina Section and AADR San Francisco Section. She is currently Chair, AADR Ethics in Dental Research Committee.  Weintraub serves as a reviewer for the Journal of Dental Research and JDR Clinical &Translational Research. She has given presentations in seven invited symposia, along with 25 first-authored and 62 co-authored abstracts at AADR/IADR meetings. Weintraub is an AADR Fellow and the recipient of the 2009 IADR H. Trendley Dean Memorial Award for meritorious research in epidemiology and public health.

International Association for Dental Research

The International Association for Dental Research (IADR) is a nonprofit organization with over 10,000 individual members worldwide, with a Mission to drive dental, oral and craniofacial research to advance health and well-being worldwide. To learn more, visit www.iadr.org. The American Association for Dental Research (AADR) is the largest Division of IADR with over 3,000 members in the United States. To learn more, visit www.iadr.org/aadr.

 







IADR Elects Brian O'Connell as IADR Vice-President

Posted on Monday, December 16, 2019

Members of the International Association for Dental Research (IADR) have elected Brian O’Connell, Trinity College, Dublin, Ireland, to serve as the IADR Vice-president. His term will commence at the conclusion of the 98th General Session of the International Association for Dental Research (IADR), which will be held in conjunction with the 49th Annual Meeting of the AADR and the 44th Annual Meeting of the Canadian Association for Dental Research (CADR), from March 18-21, 2020 in Washington, D.C., USA.

O’Connell received a Bachelor of Dental Surgery at the National University of Ireland, Cork and a Ph.D. in biochemistry and a Specialty Certificate in Prosthodontics at the University of Rochester, New York, USA. Currently he is a Professor of Restorative Dentistry and Dean of Dental Affairs at the Dublin Dental University Hospital at Trinity College, Dublin, Ireland.

With a background in biochemistry and prosthodontics, O’Connell’s research has ranged from salivary proteins to gene transfer, dental implants, bruxism and ageing. He has written more than 90 peer-reviewed papers with over 4,000 citations and presented his research across the world.

Since joining IADR/AADR in 1983, he has held several IADR leadership positions including IADR Treasurer, IADR Pan European Region Treasurer and Board member, IADR Regional Board member for the Pan European Region, President, Council member and founding member of the Irish Division of IADR, Journal of Dental Research Editorial Board member and Chair of IADR Regional Development Program Committee. O’Connell was a1992 IADR Unilever Hatton Award winner.

International Association for Dental Research

The International Association for Dental Research (IADR) is a nonprofit organization with over 10,000 individual members worldwide, with a Mission to drive dental, oral and craniofacial research to advance health and well-being worldwide. To learn more, visit www.iadr.org.







Henry Schein Celebrates 21st Annual ‘Holiday Cheer for Children’ Program With Families Around the World

Posted on Monday, December 16, 2019

Team Schein Members Donate Gifts, Clothing, and More to Participating Children, Families, and Seniors


Henry Schein, Inc. (Nasdaq: HSIC) and Team Schein Members (TSMs) around the world joined more than 1,200 underserved children, families, and seniors to celebrate the Company’s 21st annual Holiday Cheer for Children program, a flagship corporate initiative that helps participating families enjoy a fun and festive holiday season.

TSMs from more than 20 Company locations participated in the program, spreading holiday cheer to kids in the U.S., Australia, Canada, Ireland, Italy, New Zealand, Spain, and the U.K. Holiday Cheer for Children takes different forms depending on the location, with TSMs often collecting and donating gifts and food to local nonprofit organizations, or purchasing gifts for participating children and delivering them at Company events. Henry Schein partners with local social service agencies to identify children and families who would most benefit from participating in the program.

“The Holiday Cheer for Children program exemplifies our Company’s mission to support the communities in which we live and work, and the joy of celebrating with new friends and families each year only serves to reinforce our commitment to giving back,” said Gerry Benjamin, Henry Schein’s Executive Vice President and Chief Administrative Officer. “It is especially rewarding to see the friendships that have formed between our TSMs, our social service agency partners, and the families we serve, and we look forward to making many more new friends in the years to come.”

The Company hosted its largest Holiday Cheer for Children event December 5 at its global headquarters in Melville, New York, where more than 550 children opened their presents, enjoyed dinner, games, and music, and visited with Santa Claus. Participating children and families at the Melville event were identified for participation by the following local social service agencies: Bethany House, Espoir Youth Program, Family & Children’s Association, Family Service League, Hispanic Counseling Center, Madonna Heights, Nassau County Department of Social Services, The Raymar Children’s Fund, WellLife Network, and YES Community Counseling Center.

“Team Schein has long been a valued partner in our efforts to ensure that our clients, regardless of their circumstances, experience the wonder of the holiday season,” said Donna Teichner, Assistant Vice President, Preventive Services, for Family & Children's Association. “The Holiday Cheer for Children program is a highlight of the season for many of the families and children with whom we work, and we thank Henry Schein and TSMs around the world for their generosity.”

Holiday Cheer for Children is an initiative of Henry Schein Cares, the company’s global corporate social responsibility program, and is supported by the Henry Schein Cares Foundation, Inc., a 501(c)(3) organization that works to foster, support, and promote dental and overall health by helping to increase access to care for communities around the world.

About Henry Schein Cares

Henry Schein Cares stands on four pillars: engaging Team Schein Members to reach their potential, ensuring accountability by extending ethical business practices to all levels within Henry Schein, promoting environmental sustainability, and expanding access to health care for underserved and at-risk communities around the world. Health care activities supported by Henry Schein Cares focus on three main areas: advancing wellness, building capacity in the delivery of health care services, and assisting in emergency preparedness and relief.

Firmly rooted in a deep commitment to social responsibility and the concept of enlightened self-interest championed by Benjamin Franklin, the philosophy behind Henry Schein Cares is a vision of “doing well by doing good.” Through the work of Henry Schein Cares to enhance access to care for those in need, the Company believes that it is furthering its long-term success. To learn more about how Henry Schein Cares is making a difference, please visit: www.henryschein.com/socialresponsibility.

About the Henry Schein Cares Foundation, Inc.

Established in 2008, the Henry Schein Cares Foundation works to foster, support, and promote dental and overall health by helping to increase access to care in communities around the world. The Henry Schein Cares Foundation carries out its mission through financial and health care product donations to non-profit organizations supporting health care professionals and community-based programs focused on prevention, wellness, and treatment; disaster preparedness and relief; and capacity building of health institutions that provide training and care.

The Foundation is a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. Contributions to the Foundation are tax-deductible as provided by law.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratoriesgovernment and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries. The Company's sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.comFacebook.com/HenrySchein, and @HenrySchein on Twitter.







NYU Dentistry’s Nicola Partridge Named Fellow of the American Association for the Advancement of Science

Posted on Monday, December 16, 2019

Partridge Recognized for Research on the Biology and Formation of Bone

Nicola Partridge, a professor of basic science and craniofacial biology at NYU College of Dentistry, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.

This year’s Fellows “have been awarded this honor by AAAS because of their scientifically or socially distinguished efforts to advance science or its applications,” the association said. The new Fellows will be recognized in February at the 2020 AAAS Annual Meeting in Seattle.

As part of the Section on Biological Sciences, Partridge was elected as an AAAS Fellow for her expertise in molecular endocrinology and bone and mineral research. Specifically, she studies the role of parathyroid hormone action in bone and mineralized tissue, including the regulation of gene expression by the osteoblast (a cell that forms new bone). This research may inform new treatments for osteoporosis.

AAAS is the world’s largest general scientific society and publisher of the journal Science, as well as Science Translational Medicine; Science Signaling; a digital, open-access journal, Science Advances; Science Immunology; and Science Robotics. This year’s AAAS Fellows were formally announced in the AAAS News & Notes section of Science on November 29. The tradition of AAAS Fellows began in 1874.







MouthWatch Names Four Winners of its Second Annual “Teledentistry Innovation Awards” During GNYDM 2019

Posted on Friday, December 13, 2019


2019 Tellie Awards Winners (L-R) Angie Stone, RDH, Paul Glassman, DDS, Paul Labbe, DDS, Brant Herman, CEO MouthWatch, LLC (Miquel McRae, RDH was not able to attend and accepted her award via video conference).

MouthWatch, LLC a leader in dentist-managed teledentistry solutions, digital case presentation tools and intraoral imaging devices, recognized four teledentistry pioneers during its second annual Teledentistry Innovation Awards, affectionately known as the “Tellies”. The awards were presented during an exclusive invitation-only event hosted during the recent Greater New York Dental Meeting.

The purpose of the Tellie Awards is two-fold:

1.) Highlight the many ways that teledentistry is being implemented across a broad spectrum of dental care including public health, private    practice and organizational settings.

2.) Recognize individual, forward-thinking dental providers who are realizing the full potential for connected dental care technology and who are reshaping the practice of dentistry while improving the state of oral health across the country.

According to MouthWatch Founder and CEO Brant Herman, “The Teledentistry Innovation Awards continue to grow each year thanks to expanded industry awareness and the increase of new implementations that are broadening the perception of what teledentistry is and what it can do to improve the delivery of patient care.” Here are 2019 Tellie Awards winners:

Teledentistry Pioneer Award:

Paul Glassman, DDS, MA, MBA / University of the Pacific, Stockton, CA

Dr. Glassman is the first recipient in the newly created “Teledentistry Pioneer” category.  He is the founder of the Virtual Dental Home Program, whereby he and his team at the University of the Pacific developed a more efficient way to connect patients to dental care through the combination of technology and innovation. This care-delivery model, combined with his efforts in education, in supporting legislative changes that support teledentistry and improve access to care have helped create a landscape where more and more programs and providers are interested in teledentistry and the opportunities it creates.

Dental Innovator:

Paul Labbe, DDS / Planet Dental, Laredo TX

Dr. Labbe is a pediatric dentist with 5 office locations. He uses teledentistry to provide care to underserved children in his community. Teledentistry enables him and his team to conduct  dental screenings at local schools and then in turn, provide the parents and guardians with diagnosis and treatment plans with the option to bring their children to one of his offices for restorative treatment.

Hygiene Innovator:

Angie Stone, RDH / Hylife Oral Health Alliance, Edgerton, WI

Angie and her team of oral care specialists provide onsite hygiene services to elderly patients who live in nursing homes, assisted living facilities and private homes. They use teledentistry to document each patient visit with intraoral photos and videos and to communicate with family members and participating dentists to ensure that their clients receive restorative care when needed.

Oral Health Program Innovator:

Miquel McRae, RDH,  CDHC / ToothBUDDS, Pima, AZ

Miquel founded ToothBUDDS, a non-profit that employs a team of dental hygienists to provide oral care to underserved children in her area – Many of which have some form or oral disease. Miquel and her team provide education, screenings, cleanings and fluoride treatments in local school settings. Thanks to teledentistry, they can connect children with urgent dental needs to a local dentist, so they don’t fall through the cracks. (Miquel was not able to attend the event and accepted her award via video conference.)

“We congratulate and thank this year’s Teledentistry Innovation Award winners for their commitment to using teledentistry technology to make a tangible difference in improving access to care and the state of oral health in their communities, “ adds Herman. Nominations for next year’s Tellie Awards are currently being accepted online at https://teledentistryinnovationawards.com/. Self-nominations are welcome.

About MouthWatch, LLC

Headquartered in Metuchen, New Jersey, MouthWatch, LLC is a leader in leader in innovative teledentistry solutions, digital case presentation tools and intraoral imaging devices. The company is dedicated to finding new ways to constantly improve the dental health experience for both patient and provider. For more information, visit www.MouthWatch.com.







Saliva test shows promise for earlier and easier detection of mouth and throat cancer

Posted on Friday, December 13, 2019

A novel non-invasive technique may detect human papilloma virus-16, the strain associated with oropharyngeal cancer, in saliva samples, reports The Journal of Molecular Diagnostics

Unfortunately, cancers that occur in the back of the mouth and upper throat are often not diagnosed until they become advanced, partly because their location makes them difficult to see during routine clinical exams. A report in The Journal of Molecular Diagnostics, published by Elsevier, describes the use of acoustofluidics, a new non-invasive method that analyzes saliva for the presence of human papilloma virus (HPV)-16, the pathogenic strain associated with oropharyngeal cancers (OPCs). This novel technique detected OPC in whole saliva in 40 percent of patients tested and 80 percent of confirmed OPC patients.

“OPC has an approximate incidence of 115,000 cases per year worldwide and is one of the fastest-rising cancers in Western countries due to increasing HPV-related incidence, especially in younger patients. It is paramount that surveillance methods are developed to improve early detection and outcomes,” explained co-lead investigator Tony Jun Huang, PhD, Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, USA.

“Considering these factors, the successful detection of HPV from salivary exosomes isolated by our acoustofluidic platform offers distinct advantages, including early detection, risk assessment and screening,” added Dr. Huang. This technique may also help physicians predict which patients will respond well to radiation therapy or achieve longer progression-free survival.

Exosomes are tiny microvesicles originating within cells that are secreted into body fluids. They are believed to play a role in intercellular communication and their numbers are elevated in association with several types of cancers. Acoustofluidics is an advanced technology that fuses acoustics and microfluidics. Fluid samples are analyzed using a tiny acoustofluidic chip developed to isolate salivary exosomes by removing unwanted particles based on size, leaving exosome-rich concentrated samples that make it easier to detect tumor-specific biomarkers.


Acoustofluidic exosome isolation chip for salivary exosome isolation. The microfluidic channel is shown by red dye solution and the coin demonstrates the size of the chip. Two pairs of gold interdigital transducers are deposited along the channel, which separates particles according to size.

In this study investigators analyzed saliva samples from 10 patients diagnosed with HPV-OPC using traditional methods. They found that the technique identified the tumor biomarker HPV-16 DNA in 80 percent of the cases when coupled with droplet digit PCR. Since this method is independent of sample variability that arises due to changes in saliva viscosity and collection methods used, it may prove ideal for use in clinical settings.

Dr. Huang highlighted some of the technique’s features, including automated and fast exosome isolation (less than five minutes of processing time compared to approximately eight hours of processing time using benchmark technologies). Analyses can be performed at relatively low cost and at points of care. Also, it is suitable for repeated and continuous monitoring of tumor progression and treatment, unlike traditional biopsy.

“With these features, the acoustofluidic technology has the potential to significantly exceed current industry standards, address unmet needs in the field, help expedite exosome-related biomedical research, and aid in the discovery of new exosomal biomarkers,” commented Dr. Huang.

“The saliva exosome liquid biopsy is an effective early detection and risk assessment approach for OPC,” said co-lead investigator David T.W. Wong, DMD, DMSc, of the Center for Oral/Head and Neck Oncology Research, School of Dentistry at the University of California Los Angeles, CA, USA. “The acoustofluidic separation technique provides a fast, biocompatible, high-yield, high-purity, label-free method for exosome isolation from saliva.” According to the researchers, this technology can also be used to analyze other biofluids such as blood, urine and plasma.

The study was an international collaboration between Duke University, UCLA and University of Birmingham (UK). Prof Hisham Mehanna, Director of the Institute of Head and Neck Studies and Education, University of Birmingham, said “The results are a testament to the power of interdisciplinary research and international collaboration.”

About The Journal of Molecular Diagnostics

The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology, co-owned by the American Society for Investigative Pathology, and published by Elsevier, seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome review articles that contain: novel discoveries or clinicopathologic correlations, including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods for diagnosis or monitoring of disease or disease predisposition. jmd.amjpathol.org

About Elsevier

Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirectScopusSciValClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com







vhf Supports Regional Climate Protection in the Black Forest

Posted on Friday, December 13, 2019

vhf is particularly committed to the Black Forest near the German headquarters. The current motto of the CNC milling machine and tool manufacturer is "High Tech Meets Black Forest." With its annual Christmas donation, vhf is supporting the mountain forest initiative Bergwald Projekt in the Black Forest this year.


vhf’s support benefits the Black Forest locally and the climate globally. Ria Brandenberger, vhf board member, sums up the motivation for the donation as follows: “It is important to us that we as a company are committed to regional climate protection.” Healthy forests make a significant contribution to an optimal climate—especially in Germany, where forests account for around one third of the country’s total area. In addition to drinking water, flood, and soil erosion protection, vital near-natural forests make an important contribution to binding CO2 and therefore protecting the climate. One of the most important goals of the vhf-funded project in Forbach in the northern Black Forest is the planting of new trees. For more than 20 years, the mountain forest project has been working together with the community in the northern Black Forest (forest share over 90%).

In addition to forest management, the initiative is also engaged in landscape management and tries to prevent damage caused by wild animals. The organization is committed to the protection and maintenance of the forest and to promoting an understanding of the interrelationships in nature.

As a responsible global player, vhf has long been committed to active climate protection. All of the company’s buildings exclusively use green electricity from self-produced solar energy and hydroelectric power from the region.







Paramount Dental Studio a Pilot Customer for Pearl's Scan Clarity Score AI Product

Posted on Friday, December 13, 2019

Pearl, the AI dental care company that is delivering AI and computer vision solutions that advance efficiency, accuracy, transparency and patient care, announced that Paramount Dental Studio is a pilot customer for its launch of Scan Clarity Score—a product that addresses the inefficient and expensive process of working with poor quality intraoral scans for dental restorations.

For a patient, when it comes to getting crowns, implants, and other dental restoration products into their mouth, time can pass at a glacial pace. While dentists are eager to provide the best care and solutions to their patients' dental needs, the quality of dental scans can hold up the manufacturing process due to myriad issues: lack of a visible margin, missing contact points, or defects in the scan itself. All of this leads to costly duplications of product, assumptions and interpretation that lead to additional mistakes, and wasted administrative time between the dental practice and the dental lab. All the while the patient waits anxiously to be relieved of pain, to be able to eat regularly, or to feel confident in their physical appearance again.

Pearl's Scan Clarity Score allows dental labs to score and bucket each patient scan based on margin clarity. If the scan is of high enough quality, the margin is automatically marked and sent on for crown design. If the margin clarity score is low, it is flagged for human intervention and/or for a call to be placed to the dentist. By systematically processing the quality of margins, dental labs, dentists, and, most importantly, patients benefit from higher quality dental restorations.

Paramount Dental Studio, which has already been using Pearl for AI-powered margin marking (Pearl Smart Margin), has begun to integrate Pearl's Scan Clarity Score to increase the speed with which they can deliver dental restorations to dentists and their patients. Scan Clarity Score's ability to reduce human error and manual process iterations in the restoration process has the potential to create a bottom line impact for Paramount.

"One of the trickiest aspects of incorporating AI into our business is finding datasets large enough. Predictive modeling simply falls short if there is not enough data," said Philip Kim, CEO of Paramount Dental Studio, which has locations in Garden Grove, California, and Charlottesville, Virginia. "Pearl clearly has a big head start with its dataset, the size of which was one of the reasons we developed so much confidence in their margin scoring ability. We're looking forward to continuing to integrate Pearl AI and computer vision into our business."

Artificial intelligence deploys a combination of computer vision (the processing and understanding of digital imagery), machine learning (data-driven algorithms that enable computers to learn underlying patterns about the data they process), and predictive analytics (statistical modeling used to find or forecast patterns and outcomes). Pearl trained its AI platform on millions of images annotated by leading global experts in dentistry and uses computer vision and machine learning to identify dozens of pathologies with greater accuracy. Pearl's Scan Clarity Score is the latest product from the company to alter the dental care landscape.

"After seeing strong interest in our Smart Margin product, the launch of Scan Clarity Score is a natural next step, with strong applicability to the dental laboratory market," said Ophir Tanz, CEO of Pearl. "The cost and efficiency savings enabled by Scan Clarity Score also underscore the big potential AI has for dental laboratories. We look forward to continuing to roll out new AI and computer vision features for dental providers, DSOs, dental insurers and dental laboratories alike."







Recent Headlines

© 2024 BroadcastMed LLC | Privacy Policy